Edwin Coe advised Onzima Ventures Plc on the acquisition of the remaining 51% of the issued shares of N4 Pharma Limited which it did not already own. The transaction constituted a Reverse Takeover and entailed the re-admission of the enlarged entity to AIM.

The company also raised £1.5 million via a share placing which, it said, will be used to fund the development of additional patent applications for reformulations of a wide range of generic drugs, to undertake clinical trials for N4 Pharma’s reformulation of sildenafil and for working capital purposes.

The Edwin Coe team was led by Head of Corporate & Commercial Russel Shear, who commented: “We are delighted to have assisted Onzima Ventures on this acquisition and its re-admission to AIM as N4 Pharma.”

About Edwin Coe

Edwin Coe LLP is a full service law firm based in the heart of London’s historic legal district in Lincoln’s Inn. Founded in 1913, we have grown from our litigation origins to become a thriving and dynamic practice, providing a comprehensive range of legal services to meet the needs of a wide variety of businesses, individuals and organisations based throughout the UK and internationally.

With 43 Partners, we are ranked 115 in the 2022 edition of The Lawyer ‘UK 200’ law firms and are recommended in all the major legal directories. We provide clients with innovative, tailored and integrated legal services and combine a highly personal and responsive service with industry leading expertise.

Latest News & Events See All

Share by: